Copperwynd Financial, LLC Dexcom Inc Transaction History

Copperwynd Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$67.99 - $132.89 $305,411 - $596,941	-4,492 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$94.08 - $130.2 $422,607 - $584,858	4,492 New	4,492 $2.3 Million
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $1.38 Million - $1.85 Million	-17,729 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $155,776 - $184,221	1,631 Added 10.13%	17,729 $7.31 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $1.01 Million - $1.7 Million	16,098 New	16,098 $6.53 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.